Cargando…

Empagliflozin: Novel antidiabetes and pro-cardiac drug

Detalles Bibliográficos
Autores principales: Raut, Monish S, Maheshwari, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444227/
https://www.ncbi.nlm.nih.gov/pubmed/28584358
http://dx.doi.org/10.4103/ija.IJA_105_17
_version_ 1783238683129806848
author Raut, Monish S
Maheshwari, Arun
author_facet Raut, Monish S
Maheshwari, Arun
author_sort Raut, Monish S
collection PubMed
description
format Online
Article
Text
id pubmed-5444227
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54442272017-06-05 Empagliflozin: Novel antidiabetes and pro-cardiac drug Raut, Monish S Maheshwari, Arun Indian J Anaesth Letters to Editor Medknow Publications & Media Pvt Ltd 2017-05 /pmc/articles/PMC5444227/ /pubmed/28584358 http://dx.doi.org/10.4103/ija.IJA_105_17 Text en Copyright: © 2017 Indian Journal of Anaesthesia http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Letters to Editor
Raut, Monish S
Maheshwari, Arun
Empagliflozin: Novel antidiabetes and pro-cardiac drug
title Empagliflozin: Novel antidiabetes and pro-cardiac drug
title_full Empagliflozin: Novel antidiabetes and pro-cardiac drug
title_fullStr Empagliflozin: Novel antidiabetes and pro-cardiac drug
title_full_unstemmed Empagliflozin: Novel antidiabetes and pro-cardiac drug
title_short Empagliflozin: Novel antidiabetes and pro-cardiac drug
title_sort empagliflozin: novel antidiabetes and pro-cardiac drug
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444227/
https://www.ncbi.nlm.nih.gov/pubmed/28584358
http://dx.doi.org/10.4103/ija.IJA_105_17
work_keys_str_mv AT rautmonishs empagliflozinnovelantidiabetesandprocardiacdrug
AT maheshwariarun empagliflozinnovelantidiabetesandprocardiacdrug